Goodwin
Mitch Bloom
- Deals
- 3
- Latest
- Aug 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 3 deals
Often works with
- Adam Dilluvio 2 deals together
- Kenny Walker-Durrant 1 deal together
- Tevia Pollard 1 deal together
- Marianne Sarrazin 1 deal together
- Rob Dzialo 1 deal together
- Tim Ayotte 1 deal together
- Dylan Miller 1 deal together
- Ben Colao 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Aug 2026 | Slate Medicines | – | Fulcrum Therapeutics | Merger | Legal adviser to Fulcrum Therapeutics | Announced | – | Biotech+1 | Fulcrum Therapeutics and Slate Medicines merger |
| Jul 2026 | Myricx Bio | – | Novartis | Acquisition | Legal adviser to Myricx Bio (target) | Announced | 1,100.0 | Biotech+1 | Novartis acquisition of Myricx Bio |
| May 2026 | Perfuse Therapeutics | – | Bayer | Acquisition | Legal adviser to Perfuse Therapeutics (target) | Announced | 300.0 | Biotech+2 | Bayer acquisition of Perfuse Therapeutics |
Deals where Mitch Bloom is named on the firm's deal team, by the firm or the press.